mRNA vaccines: Four major clinical trial readouts to watch in 2023
After their success in Covid-19, can mRNA vaccines breakthrough in influenza, herpes, and even cancer?

After their success in Covid-19, can mRNA vaccines breakthrough in influenza, herpes, and even cancer?
The Phase I/II clinical trial will evaluate the safety and immunogenicity of the vaccine.
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
Shionogi commences Phase I/II/III and Phase III trials of Covid-19 vaccine